Cystic Fibrosis Trust, the only UK-wide charity that funds research into the disease, will standardise the use of DocuSign for Digital Transaction Management (DTM), allowing staff to increase their focus on finding a cure.
DocuSign automates non-profit organisations, allowing groups like Cystic Fibrosis Trust to reduce costs on paper processes, increase staff productivity and improve the staff, donor and volunteer experience.
By standardising DocuSign DTM, the trust can eliminate processes such as printing, faxing and scanning, which complies with Cystic Fibrosis Trust’s three year IT strategy. The charities overall strategy is to complete paperwork 100 per cent digitally using any electronic device.
‘‘The Cystic Fibrosis Trust exists to make a daily difference to the lives of people affected by cystic fibrosis,’’ commented Ed Owen, chief executive, Cystic Fibrosis Trust.
‘‘DocuSign for Nonprofits allows us to focus on this vital mission by speeding up internal processes and reducing the time and money spent on manual, paper-based administrative tasks.’’
With DocuSign, Cystic Fibrosis Trust will also be able to digitally administer its charitable programmes, including Gift Aid. This will allow staff to create an audit trail that highlights every transaction, decision and approval made within the trust.
DocuSign already help a number of charities and non-profit organisations, such as the Paralympics, the World Wildlife Fund, Scottish Autism and the American Hospital Association.
Non-profit organisations interested in learning more about DocuSign Impact and DocuSign for Nonprofits click here.
Funding will help to address critical humanitarian problems around the world
Tech for Good programme invites applications to help more charities achieve social change through technology
Colleagues at Shop Direct have raised £210,000 in just 12 months to support the development of a new digital app for Alder Hey Children’s Hospital
New digital investment service for charities will provide access to the biggest selection of charity-specific investment funds